ABBVIE 15/45ABBVIE 15/45ABBVIE 15/45

ABBVIE 15/45

No trades
See on Supercharts

4ABB analysis



Key facts


Issue date
May 14, 2015
Maturity date
May 14, 2045
Outstanding amount
‪2.70 B‬USD
Face value
1,000.00USD
Minimum denomination
2,000.00USD
Coupon
4.70% (Fixed)
Yield to maturity
5.95%
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.
Go deeper with bond data
Access the most important data for bonds including coupon rates, issue ratings, redemption data and more.